Stimulant Deaths Surge While Recovery Efforts Face Scrutiny: What's Driving the Crisis?
Stimulant deaths surged 40% in Australia in 2024, pushing overdose fatalities to 2,005 as cocaine and meth reshape the nation's drug crisis.
27 articles
Stimulant deaths surged 40% in Australia in 2024, pushing overdose fatalities to 2,005 as cocaine and meth reshape the nation's drug crisis.
End-stage alcoholism causes irreversible organ damage and can be fatal, but recognizing the six stages early makes life-saving intervention possible.
Teens now outpace adults in mental health treatment access, with 27.6% receiving care versus 21.6%, exposing a gap that affects millions seeking addiction.
Summer break can trigger anxiety and risky substance use in college students; experts urge parents to talk openly about mental health and fentanyl risks.
SAMHSA's 2025 drug use survey reveals shifting substance use patterns nationwide, with four years of vaping trend data published for the first time.
Vaping cuts young adults' exercise capacity by 15%, a new study finds, with cardiovascular damage rivaling that of cigarette smokers.
Arizona's fentanyl overdose death rate now surpasses West Virginia's as a deadly shift from pills to unpredictable powder drives record fatalities.
Wisconsin cut overdose deaths 35% in two years using naloxone, medication treatment, and peer support programs that meet people where they are.
The DEA plans to ban 7-hydroxymitragynine, a kratom extract up to 100 times stronger than morphine, raising urgent health and addiction concerns.
Targeted ultrasound eliminated opioid cravings in 20 minutes for a man taking 130 pills daily, leaving him completely addiction-free within a week.
Women now make up 90% of one counselor's gambling addiction clients, a surge driven by betting apps, life stress, and gaps in treatment designed for men.
Teen vaping affects 1.44 million U.S. teens, and flavored e-cigarettes are why rates stay high despite broader tobacco progress.
Kentucky's largest addiction treatment provider faces federal fraud charges after allegedly double-selling tax credits and overbilling Medicaid by $70.
CU Anschutz researchers developed Nezavist, an alcohol relapse drug that targets the gut, not the brain, and is now entering Phase 1 human safety trials.
Data shows 12-step programs rank eighth out of 14 addiction therapies used in the US, yet media keeps casting them as the villain blocking recovery.
Canada's overdose deaths dropped 23% in 2025, driven by wider naloxone access and $145 million in federal funding, though experts warn the crisis is far.
Mexico's 3,000 unregulated rehab centers forcibly admit addiction patients, but new legislation could transform these dangerous anexos into lifesaving.
Up to 50% of teens who vape nicotine also use cannabis through identical devices, tripling psychosis risk and creating invisible addiction patterns.
England's free vape program successfully increased quit attempts among smokers, with data showing the policy effectively shifts people away from.
Low addiction literacy fuels stigma against people in recovery, but Americans with better knowledge are 50% less likely to discriminate.
Daily cannabis use affects 8-11% of adults and can cause severe nausea, heart disease, and cognitive impairment that many users don't expect.
Canada's addiction treatment system spends tens of thousands per person yet collects almost no data on whether programs actually work.
Victoria deploys 20 naloxone vending machines statewide to combat opioid overdose deaths, offering free 24/7 access to life-saving medication.
Pets trigger measurable brain changes that lower stress hormones and boost bonding chemicals, making them powerful allies in addiction recovery.
A landmark study of 1,146 participants found that engagement depth matters more than group type in addiction recovery programs.
Ketamine shows promise for treatment-resistant depression when medically supervised, but Matthew Perry's death highlights deadly risks of unsupervised use.
Brain recovery from addiction begins within days and reaches major milestones in 3-12 months, with neuroplasticity enabling complete healing.